Stay updated on VinMetAtezo: Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the VinMetAtezo: Stage IV NSCLC Clinical Trial page.

Latest updates to the VinMetAtezo: Stage IV NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, signaling a new page version. This likely reflects maintenance or a small content refresh rather than a substantive change to the information presented.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedAdded a Locations section listing multiple French study sites (cities and addresses) for NCT03801304, expanding where participants can enroll. The update also includes a related publication citation and a note about study results to enhance context and transparency.SummaryDifference1%

- Check35 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous v3.6.0 and indicating a newer build of the page. This update does not alter study details or the information presented to users.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page now shows that recruitment has ended and adds new guide sections (How to Read a Study Record, Common Questions, How to Join a Study), improving clarity for users seeking participation information. The revision log reflects a move to version 3.6.0, replacing 3.5.5.SummaryDifference0.4%

- Check56 days agoChange DetectedThe page revision tag has been updated to v3.5.5, indicating a recent site update.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page footer revision marker was updated from Revision: v3.5.3 to Revision: v3.5.4, reflecting a new build/version update. This update is a minor metadata change and does not modify the study content or functionality.SummaryDifference0.1%

Stay in the know with updates to VinMetAtezo: Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VinMetAtezo: Stage IV NSCLC Clinical Trial page.